RIGL – rigel pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
11/19
11:53 am
rigl
Low
How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28% [Yahoo! Finance]
11/14
10:12 am
rigl
Low
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Piper Sandler from $15.00 to $23.00. They now have a "neutral" rating on the stock.
11/12
02:31 pm
rigl
Low
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $40.00 to $49.00. They now have a "buy" rating on the stock.
11/12
08:05 am
rigl
Medium
Rigel to Present at the Jefferies London Healthcare Conference
11/8
02:48 am
rigl
High
Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
11/7/2024
04:01 pm
RIGL
42.9%
BEAT
8/6/2024
04:01 pm
RIGL
5.8%
BEAT
5/7/2024
04:01 pm
RIGL
-16.6%
MISS
3/5/2024
04:01 pm
RIGL
5.4%
BEAT
11/12
01:32 pm
Maintains
Buy
Buy
Citigroup
Low
-2.5%
11/12
01:32 pm
Maintains
Buy
Buy
Citigroup
Low
-2.5%
10/25
08:37 am
Reiterates
Buy
Buy
HC Wainwright
Low
-1.0%
9/20
01:29 pm
Reiterates
Neutral
Neutral
Cantor Fitzgerald
Low
-0.6%
9/20
12:29 pm
Reiterates
Neutral
Neutral
Cantor Fitzgerald
Low
0.4%
11/14
05:18 pm
rigl
High
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC
11/14
03:33 pm
rigl
Low
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: Soleus Capital Master Fund, L.P.
11/8
09:34 am
rigl
High
Form SC 13G RIGEL PHARMACEUTICALS Filed by: Invesco Ltd.
11/7
04:25 pm
rigl
High
Form 8-K RIGEL PHARMACEUTICALS For: Nov 07
11/7
04:09 pm
rigl
High
Form 10-Q RIGEL PHARMACEUTICALS For: Sep 30
Show more
Top News Gainers
1/13 Form 8-K RIGEL PHARMACEUTICALS For: Jan 13 20.0%
10/23 Here's Why Rigel Pharmaceuticals Stock Jumped as Much as 10.7% Today [The Motley Fool] 17.1%
4/27 Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update 9.0%
2/27 Rigel Pharmaceuticals, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] 6.5%
6/28 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.5%
3/4 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.4%
5/23 Form 4 RIGEL PHARMACEUTICALS For: May 22 Filed by: Schorno Dean L 5.9%
5/21 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.9%
9/23 Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia 5.1%
8/6 Q2/2019 6/30/2019 EPS -0.120 ZacksConsensus -0.140 ActVsEst 0.020 - Beat 4.6%
Top News Decliners
4/1 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.75 price target on the stock. -11.9%
11/6 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -9.9%
5/7 Form 8-K RIGEL PHARMACEUTICALS For: May 07 -7.4%
12/17 Rigel Announces Chief Commercial Officer Transition -6.4%
8/10 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $2.50 price target on the stock. -6.4%
4/30 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.8%
10/29 Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results -5.7%
5/1 Rigel Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders -5.5%
10/18 Rigel Pharma not quite there with European application for fostamatinib [Seeking Alpha] -4.9%
9/26 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $7.00 price target on the stock. -4.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3